Tag: Novo Nordisk A/S

Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge

Novo Nordisk’s raised forecast fails to change the debate over its obesity business

Novo Nordisk shares slide after guidance disappoints investors

Novo Nordisk shares dive after heart medicine fails trial, dealing another blow to its pipeline

Why shareholders are suing Novo Nordisk over next-generation weight-loss drug

Here are 4 forces that drove a tough week for stocks

Logistics giants are racing to keep up with healthcare boom as GLP-1s highlight need for cold storage

Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials

Trump plans generic drug tariffs from 2028 with two-year delay testing U.S. onshoring push

Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising